Overwhelming medical evidence exists that the vast majority of affected children will spontaneously realign their gender identity with their biological sex when left alone
WASHINGTON, D.C -- Drugs that are being used as a puberty blocker in gender-confused youth have been linked to tens of thousands of serious reactions and thousands of deaths, as well as other serious medical issues, according to Food & Drug Administration (FDA) data.
The FDA has now documented over 41,000 adverse reactions suffered by patients who took Leuprolide Acetate, known as Lupron, which is used as a hormone blocker. There have been 25,645 reactions considered “serious,” including 6,379 deaths.
Lupron is traditionally used for treatment of prostate cancer as it inhibits the flow of testosterone over the prostate. The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age. However, it is being prescribed off-label for use in children who have been diagnosed with gender dysphoria, despite the lack of formal FDA approval for that purpose and the absence of any peer-reviewed studies done on the drug's long-term effects.
Lupron and synthetic hormones have been documented to contribute to physical problems such as blood clots and other cardiovascular complications, brittle bones and faulty joints, altered psyches, and permanent sterilization. Yet many of the long-term repercussions will not be felt for years.
Despite these serious issues, sales of Lupron were approximately $669 million in 2017 in the United States alone.
In an interview with The Christian Post, Dr. Michael Laidlaw, a California-based pediatric endocrinologist, stated that he knows of no other psychological condition that is treated by administering hormones out of alignment from their normal levels. When injected into a physically healthy body, the drug interrupts a normally-functioning endocrine system and causes a condition where the male testes or the female ovaries produce little or no sex hormones.
Currently doctors are giving testosterone to gender-confused girls as young as eight years old and teen girls as young as 13 are having their breasts removed via mastectomy procedures. Boys the age of 17 can have penises the developmental age of a nine-year-old’s or lose sexual sensation all together due to hormone blockers.
Dr. Laidlaw said, “Gender dysphoria is not an endocrine condition, but is a psychological one and should, therefore, be treated with proper psychological care. But it becomes an endocrine condition once you start using puberty blockers and giving cross-sex hormones to kids. There have been few physicians willing to stand up and say, 'We need to question this, there is something wrong here. Why are we using cancer drugs on kids without cancer and stopping normal puberty?” Laidlaw said.
Dr. Paul Hruz, another pediatric endocrinologist who spoke with The Christian Post, said that overwhelming medical evidence exists that the vast majority of affected children will spontaneously realign their gender identity with their biological sex when left alone. He also stated that the largest studies that have been done in post-transition adults continue to show rates of death by suicide that are markedly above the background population.
“The reality is that there is no long-term data about treating children, and the only data that we have in adults indicates that medical interventions to align the appearance of the body to a transgendered identity does not fix the problem,” Hruz said.
Liberty Counsel is an international nonprofit, litigation, education, and policy organization dedicated to advancing religious freedom, the sanctity of life, and the family since 1989, by providing pro bono assistance and representation on these and related topics.
WASHINGTON, D.C -- Drugs that are being used as a puberty blocker in gender-confused youth have been linked to tens of thousands of serious reactions and thousands of deaths, as well as other serious medical issues, according to Food & Drug Administration (FDA) data.
The FDA has now documented over 41,000 adverse reactions suffered by patients who took Leuprolide Acetate, known as Lupron, which is used as a hormone blocker. There have been 25,645 reactions considered “serious,” including 6,379 deaths.
Lupron is traditionally used for treatment of prostate cancer as it inhibits the flow of testosterone over the prostate. The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age. However, it is being prescribed off-label for use in children who have been diagnosed with gender dysphoria, despite the lack of formal FDA approval for that purpose and the absence of any peer-reviewed studies done on the drug's long-term effects.
